Beike Bio is a research and development company of stem cell biotherapy technology, mainly engaged in clinical transformation and technical services of biotherapy technology in strategic emerging industries, with a variety of internationally advanced immunotherapy technologies and products. Its ALT803 is considered by NCI as a promising interleukin drug for the treatment of cancer.
More peer analysis, the company knows and understands.